“State-backed vaccine manufacturer Biovac has entered into a partnership with California-based

ImmunityBio for local production of its candidate COVID-19 vaccine,” reported Business Day (19 March 2021). This paves the way for Biovac to develop the expertise to make active pharmaceutical ingredients (APIs).

Biovac has also recently collaborated with Wits University’s antiviral gene therapy unit where Biovac’s staff are being trained to handle viral vaccines.

Other news